Defying the Odds: Orbillion Bio Raising Capital for Cultivated Meat in 2024

Business for Good Podcast

If you follow the cultivated meat sector, you know that the last couple years have been tough. Some companies have gone under, others have gone into hibernation, and others have shed staff in cash-conserving layoffs. Major publications have published opinion column obituaries for this industry, yet the work goes on. Part of that work is that of Obillion Bio, a B2B cultivated meat company which successfully raised capital in 2024, surely a Herculean feat.

Having now brought in $15 million, while the Orbillion technology is complex, the business model is simple: grow high-quality wagyu beef cells and then sell those cells to others who will create finished goods with them.

In this conversation, Orbillion CEO Patricia Bubner and I chat about what makes them different from other cultivated meat startups, her work as a plant and fungal biologist prior to her career in mammalian cell culture, what she thinks are the best ways to scale, why she thinks she was successful in fundraising during a funding famine, and more.

Discussed in this episode

• Patricia is a fan of John Steinbeck’s books.

• Patricia co-founded The Millet Project.

• Orbillion went through the Y Combinator accelerator program

• Patricia and Paul both recommend Hannah Ritchie book, Not The End of the World. You can see Paul’s review of it here.

• AgFunder News on Orbillion Bio.

More about Patricia Bubner, PhD

Patricia Bubner is a PhD scientist and engineer focused on commercializing cultivated beef. She is the co-founder and CEO of Orbillion Bio, Inc. with the mission to make sustainable, nutritious, and flavorful cultivated meat at price parity.

Patricia grew up in Graz, Austria, surrounded by an abundance of local and regional foods. With farmers as grandparents, she learned early where food comes from and the hard work that goes into producing it. Her deep interest in food — and the molecular basis of food — led her to study chemistry.

Patricia holds an MSc in Technical Chemistry and a PhD in Biotechnology from Graz University of Technology in Austria, and she conducted her postdoctoral research at the Energy Biosciences Institute at UC Berkeley. During that time, she also pursued her conviction of a more sustainable food system as a co-founder of the agriculture and food systems initiative, The Millet Project.

Prior to Orbillion, Patricia advised several technology companies and led the Analytics and QC teams at biopharma startups. During her time with the Bioprocess Science team at Boehringer Ingelheim (BI), she built and led a team dedicated to scaling bioprocess development for mammalian cells — the very systems required to commercialize cultivated meat. At BI, Patricia met and worked hand-in-hand with Orbillion co-founder, Samet Yildirim, on a novel bioprocessing technology now commercialized by Pfizer.

Combining her experience in the biopharma, food, and sustainable materials industries, Patricia co-founded Orbillion Bio, Inc. Orbillion is a B2B cultivated meat technology company that brings commercially viable meat to the ever-growing $211B global ground beef market. Orbillion has developed a game-changing algorithm for the scale-up of cultivated meat that makes commercializing low-cost cultivated beef possible.

Orbillion has raised $15M and is backed by The Venture Collective, Y Combinator, At One Ventures, Venture Souq, and Metaplanet among others.